225.56 USD
↘ 2.16 (0.95%)LIVE (AS OF 02:20 PM EDT)
Axsome Therapeutics, Inc
AXSMNASDAQ • USD
Market: OPEN
Open?$229.17
High?$231.28
Low?$224.70
Prev. Close?$227.72
Volume?273.9K
Avg. Volume?812.4K
VWAP?$227.58
Rel. Volume?0.34x
Bid / Ask
Bid?$225.91 × 100
Ask?$259.65 × 100
Spread?$33.74
Midpoint?$242.78
Valuation & Ratios
Market Cap?11.7B
Shares Out?51.5M
Float?40.3M
Float %?78.7%
P/E Ratio?N/A
P/B Ratio?214.67
EPS?-$3.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Address
ONE WORLD TRADE CENTER, 29TH FLOOR
NEW YORK, NY 10007
Phone: (212) 332-3241
NEW YORK, NY 10007
Phone: (212) 332-3241
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.39Adequate
Quick Ratio?1.32Adequate
Cash Ratio?0.69Adequate
Debt/Equity?3.55High
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?214.67HIGH▾
P/S?16.55HIGH▾
P/FCF?N/A▾
EV/EBITDA?-69.6CHEAP▾
EV/Sales?16.39HIGH▾
Returns & Efficiency
ROE?-345.0%WEAK▾
ROA?-26.4%WEAK▾
Cash Flow & Enterprise
FCF?$-70993000
Enterprise Value?$11.6B
Fundamentals ratios updated end of day